BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 25840993)

  • 1. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
    Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
    J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
    Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
    J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation.
    Li Q; Zou J; Wang M; Ding X; Chepelev I; Zhou X; Zhao W; Wei G; Cui J; Zhao K; Wang HY; Wang RF
    Nat Commun; 2014 Dec; 5():5780. PubMed ID: 25531312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
    Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
    FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation.
    Manna S; Kim JK; Baugé C; Cam M; Zhao Y; Shetty J; Vacchio MS; Castro E; Tran B; Tessarollo L; Bosselut R
    Nat Commun; 2015 Sep; 6():8152. PubMed ID: 26328764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
    Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.
    Wu W; Qin M; Jia W; Huang Z; Li Z; Yang D; Huang M; Xiao C; Long F; Mao J; Moore PK; Liu X; Zhu YZ
    Cell Mol Immunol; 2019 Aug; 16(8):694-705. PubMed ID: 29844591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jumonji domain containing-3 (JMJD3) inhibition attenuates IL-1β-induced chondrocytes damage in vitro and protects osteoarthritis cartilage in vivo.
    Jun Z; Xinmeng J; Yue L; Zhi W; Yan Z; Tieyi Y; Jiangan T
    Inflamm Res; 2020 Jul; 69(7):657-666. PubMed ID: 32394143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Profiling and H3K27me3 Distribution Reveal Both Demethylase-Dependent and Independent Regulation of Developmental Gene Transcription in Cell Differentiation.
    Kang SC; Kim SK; Chai JC; Kim SH; Won KJ; Lee YS; Jung KH; Chai YG
    PLoS One; 2015; 10(8):e0135276. PubMed ID: 26263556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.
    Raveney BJ; Oki S; Yamamura T
    PLoS One; 2013; 8(2):e56595. PubMed ID: 23437182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
    Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
    J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression.
    Guo Z; Lu J; Li J; Wang P; Li Z; Zhong Y; Guo K; Wang J; Ye J; Liu P
    Mol Cell Endocrinol; 2018 Dec; 477():1-14. PubMed ID: 29753027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.